Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Scientometric Analysis and Visualization of Research on Fatty Liver Diseases in Iran From 2003 to 2023 Publisher



Taheri E1 ; Ehtesham H2 ; Safdari R3 ; Hormati A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Health Information Technology, Birjand University of Medical Sciences, Birjand, Iran
  3. 3. Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2025


Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and is now a major global health threat. Due to the mechanistic links between these conditions, along with the rising prevalence of fatty liver disease, diabetes, and obesity, MAFLD (metabolic-associatedfatty liver diseases) was introduced as a new terminology and then updated to MASLD (Metabolic Dysfunction-associated Steatotic Liver Disease. These changes reflect a growing recognition of the importance of fatty liver and its associated health risks. Methods: This scientometric study analyzed publications on “fatty liver diseases” (FLD) indexed in Scopus from 2003 to 2023 in Iran. Online Analysis Platforms and VOSviewer were used to assess publication trends and identify research hotspots. Results: We retrieved 1,857 English articles on fatty liver diseases published between 2003 and 2023. The Journal of Hepatitis Monthly was notable for Iranian publications on fatty liver disease. Most publications were original articles and Dr. Sahebkar AH was the most prolific author. Iranian researchers primarily collaborated with scholars from the United States. The leading institution in terms of productivity was Tehran University of Medical Sciences. Conclusion: This study reveals an increasing trend in both the number of Iranian publications and the citations of articles in the field of FLD. We believe this study can serve as a roadmap for future research and policy development on fatty liver diseases, which are a significant public health concern in Iran. Additionally, new strategies are needed to foster multi-disciplinary research and enhance international cooperation. © The Author(s), under exclusive licence to Tehran University of Medical Sciences 2025.
Related Docs
View other Related Docs
1. The Effects of Gut Microbiome Manipulation on Glycemic Indices in Patients With Non-Alcoholic Fatty Liver Disease: A Comprehensive Umbrella Review, Nutrition and Diabetes (2024)
2. Advancing the Global Public Health Agenda for Nafld: A Consensus Statement, Nature Reviews Gastroenterology and Hepatology (2022)
3. The Association of Food Insecurity With Non-Alcoholic Fatty Liver Disease (Nafld) in a Sample of Iranian Adults: A Path Analysis of a Cross-Sectional Survey, BMC Research Notes (2024)
4. Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease Among an Iranian Adult Population With Ethnic and Genetic Diversity: Results of the Polyiran-Liver Study, Middle East Journal of Digestive Diseases (2024)
5. Covid-19 and Mafld/Nafld: An Updated Review, Frontiers in Medicine (2023)
6. Polypill Protects Mafld Patients From Cardiovascular Events and Mortality: A Prospective Trial, Hepatology International (2023)
7. Emerging Role of Nanotechnology in Treatment of Non-Alcoholic Fatty Liver Disease (Nafld), EXCLI Journal (2023)
8. A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression, Pathology Research and Practice (2023)
Experts (# of related papers)
View all Related Experts
Amir Reza Radmard (2)
Hossein Poustchi (2)
Other Related Docs
9. Nomenclature and Definition of Metabolic-Associated Fatty Liver Disease: A Consensus From the Middle East and North Africa, The Lancet Gastroenterology and Hepatology (2021)